After Hours Summary:

Tuesday, February 12, 2008

After Hours Summary: AMAT +5.1% on earnings/guidance; DNA +2.4% (announces Avado study of Avastin Plus docetaxel chemotherapy showed improved progression-free survival in patients with advanced breast cancer) -Update-

Companies moving in after hours trading in reaction to earnings: Trading Up: CPSS +13.3%; BWLD +11.2%; ARP +11.2%; XPRT +11.0%; OCNF +9.1%; VOLC +8.9%; WSPI +8.8%; SSTR +8.1%; AMAT +5.1%; RICK +4.5%; QBAK +1.7%; GXDX +1.6%; BOBE +1.1%... Trading Down: NILE -20.2%; HCSG -10.3%; ATAC -10.0%; CSCD -9.0%; OSUR -6.3%; MOSY -5.6%; ANAD -5.4%; WYNN -4.1%; SYUT -2.9%; FRT -1.3%; DDR -1.3%... Companies moving in after hours trading in reaction to news: Trading Up: TYM +3.7% (announces American Stock Exchange Listing and common stock offer); DNA +2.4% (announces Avado study of Avastin Plus docetaxel chemotherapy showed improved progression-free survival in patients with advanced breast cancer); PNCL +1.5% (releases January performance data)... Trading Down: NILE -20.2% (Mark Vadon has assumed the role of Executive Chairman; Diane Irvine has been named new CEO; announced today that its Board of Directors authorized the repurchase of up to an additional $100 mln of the Co's common stock).